| Literature DB >> 32571202 |
Katherine Ka-Yin Yau1, Alice Yuen Loke2.
Abstract
The aim in this literature review was (1) to explore the physiologically and psychologically therapeutic benefits of forest bathing on adults suffering from pre-hypertension or hypertension, and (2) to identify the type, duration, and frequency of an effective forest bathing intervention in the management of pre-hypertension and hypertension, so as to provide directions for future interventions or research. The electronic databases PubMed, Cochrane Library, CINAHL, PsyINFO, and the China Academic Journals (CAJ) offered through the Full-text Database (CNKI) were searched for relevant studies published from the inception of the databases to April 2019. Of the 364 articles that were identified, 14 met the criteria for inclusion in this review. The synthesis of the findings in the included studies revealed that forest bathing interventions were effective at reducing blood pressure, lowering pulse rate, increasing the power of heart rate variability (HRV), improving cardiac-pulmonary parameters, and metabolic function, inducing a positive mood, reducing anxiety levels, and improving the quality of life of pre-hypertensive or hypertensive participants. Forest walking and forest therapy programs were the two most effective forest bathing interventions. Studies reported that practicing a single forest walking or forest therapy program can produce short-term physiological and psychological benefits. It is concluded that forest bathing, particularly forest walking and therapy, has physiologically and psychologically relaxing effects on middle-aged and elderly people with pre-hypertension and hypertension.Entities:
Keywords: Forest bathing; Forest therapy; Forest walking; Hypertension; Mood states; Pre-hypertensive; Shinrin-yoku; Stress level
Year: 2020 PMID: 32571202 PMCID: PMC7310560 DOI: 10.1186/s12199-020-00856-7
Source DB: PubMed Journal: Environ Health Prev Med ISSN: 1342-078X Impact factor: 3.674
Fig. 1Flow chart of the literature search process (PRISMA 2009)
Characteristics of the included studies
| Author, year, country | Study design | Sample size | Criteria for the inclusion of participants | Criteria for the exclusion of participants | Forest bathing intervention | Control/comparator | Duration and frequency of the intervention | QATSDD score (0-42) |
|---|---|---|---|---|---|---|---|---|
| Feng et al., 2017 [ | Randomized controlled trial | Mean age: 50 ± 10; non-smokers and non-drinkers; HT with or without anti-HTN drugs | DM; CAD; CVA | Forest walking | No intervention | 20 sessions; 1 session/day; walk 60-90 min/per session or walk 2 km/per session | 23 | |
| Horiuchi et al., 2015 [ | Quasi-experimental study | Mean age: 63.2 ± 9.4; taking anti-HTN drugs; non-smokers | Not specified | Forest walking (stretching; self-paced, comfortable walking) and forest viewing in a supine position | NA | 1 session; 90 min/per session | 26 | |
| Lanki et al., 2017 [ | Quasi-experimental and comparative study | Aged 30-60; not taking anti-HTN medications | Smoking; cardiac pacemaker; hearing aid; MI; CAD; CHF; Stroke, COPD | Sedentary viewing, and walking in an urban forest and urban park | Sedentary viewing and walking in the city center | 1 session; starting in the afternoon; including 15 min of sedentary viewing, 30 min of paced and unhurried walking | 25 | |
| Lee and Lee, 2014 [ | Randomized controlled trial | Aged 60-80; BP < 160/110 mmHg | Chronic liver and renal disease; CAD; CVA; cancer; disability or pain when walking; BP > 160/110 mmHg | Forest walking conducted separately 1 week apart with city walking | City walking conducted separately 1 week apart with forest walking | 1 session; 1 h of paced walking in the morning | 31 | |
| Li et al., 2016 [ | Randomized crossover trial | Aged 40-74; not taking anti-HT drugs; high normal hypertension; living in the city | Not specified | Forest walking | Urban walking | Two sessions in a day: (AM+PM); 1 h 20 min per session | 23 | |
| Mao et al., 2012 [ | Randomized controlled trial | Aged 60-75; BP < 180/110 mmHg with or without taking anti-HTN drugs; class I-II cardiac function; ADL independent | Getting the flu; acute disease 2 weeks before; cancer, chronic liver, kidney, brain, heart or lung disease; acute MI in the previous 3 months; CVA within 6 months; Hx of severe trauma or major surgery | Forest walking | City walking | 7 sessions in 7 consecutive days, 1.5 h for each session, walk in the morning or afternoon | 28 | |
| Ochiai et al., 2015a [ | Quasi-experimental study | Aged 40-72; SBP 130-139 mmHg or DBP 85-89 mmHg | Taking drugs for DM, HT, hyper-lipidemia | Forest therapy: strolling; sitting; lying down; deep breathing in a forest; riding in the forest train; strolling in an indoor pavilion | NA | One-day therapy program, 4 h 35 min | 28 | |
| Ochiai et al., 2015b [ | Quasi-experimental study | Mean age: 62.2+/−9.4; HT with or without anti-HTN drugs; no other diseases or psychological disorders | Difficulty walking in hot weather | Forest therapy: strolling, deep breathing, lying down lecture and chatting in forest; abdominal breathing with lie down position | NA | One-day therapy program, 4 h 41 min | 28 | |
| Song et al., 2017a [ | Randomized crossover trial | Aged 40-75; BP > 120/80 mmHg | Taking medication for diabetes, hyper- lipidemia, HT | Landscapes of forest viewed while sitting in chair in the afternoon | Urban area viewing while sitting in a chair in the afternoon | One session, 10 min each, conducted in 2 consecutive days | 29 | |
| Song et al., 2017b [ | Quasi-experimental study | Aged 19-56; office workers from an IT company; BP normal or SBP > 120 mmHg | Not specified | Forest therapy: preparation stretches; blind walking; deep breathing; strolling; viewing scenery and lecture; sending stress to waterfall, sitting and lying down; backwards walking; meditation; lying in a hammock | NA | One-day forest program, 6 h 12 min; date collected, 3 days before, on the day of the forest therapy, 3 days after, and 5 days after | 24 | |
| Song et al., 2015 [ | Randomized crossover trial | Mean age: 58 ± 10.6; BMI: 23.4 ± 3.3 kg.m2; SBP 130–179 mmHg; DBP 85–109 mmHg | Taking drugs for DM, hyperlipidemia, HT | Walking in a forest | Walking in urban area | One session, 17 min in 2 consecutive days | 25 | |
| Sung et al., 2012 [ | Non-randomized controlled trial | I, mean age 66+/−7; C, mean age 63+/−11; SBP 130-159 mmHg or DBP 85-99 mmHg; on anti-HTN drugs | SBP > 159 mmHg or DBP > 100 mmHg; uncontrolled hypertension and need urgent change of drug regimen; comorbidity | Cognitive behavior-based forest therapy: HTN management, motivation to make therapeutic changes in lifestyle; practicing mindfulness relaxation techniques in the forest using the five senses | Printed educational materials for HTN management; self-monitoring of BP | 3 days forest program with 8 weeks follow-up monitoring | 27 | |
| Yu et al., 2017 [ | Quasi-experimental study | Aged 45-86; chronic disease: DM, HT, heart disease, other disease | Not specified | Forest walking | NA | One session, 2 h starting in the morning | 24 | |
| Zhou et al., 2017 [ | Randomized controlled trial | Average age: 50 years; diagnosed with HT | DM; CAD; CVA | Forest walking | Walking around the highway | 20 sessions, each walk for 2 km; starting at 9:00 am | 23 |
HT hypertension; AM in the morning; PM in the afternoon; SDM semantic differential method; MI myocardial infarction; CVA cerebrovascular accident; POMS the profile of mood states; DM diabetic mellitus; COPD chronic obstructive pulmonary disease; CAD coronary artery disease; CHF congestive heart failure; HRV heart rate variability; I intervention; C control; MOS SF-36:the medical outcomes study questionnaire short-form 36 health survey; mHF mean high frequency; HRV heart rate variability; QATSDD quality assessment tool for studies with diverse designs (Sirriyeh et al.)
Summary of the physiological outcome measures of the included studies
| Reference/participants | Change in SBP (mmHg) | Change in DBP (mmHg) | Change in heart rate (bpm)/HRV (Inms2) | Change in pulse rate (bpm) | Change in other outcome measures |
|---|---|---|---|---|---|
| Types of forest intervention: forest walking | |||||
| Feng et al., 2017 [ | After forest walking, SBP was significantly lower by 13.2% in the drug group and 8% in the non-drug group. | After forest walking: DBP was significantly lower by 15.3% in the drug group and by 10.7% in the non-drug group. | NA | NA | After forest walking, total cholesterol, HDL, LDL, TG, IMT, and BaPWV improved in the drug group and non-drug group. FMD and NMD were improved remarkably in the drug group and non-drug group. |
| Lee and Lee, 2014 [ | Compared with city walking, SBP was lower by 10.26+/−13.11 mmHg (8.4%) after forest walks; compared with forest walking, SBP increased by 2.0+/−17.51 mmHg (2.6%) after city walks. | Compared with city walking, DBP was significantly lower by 9.93+/−11/15 mmHg (8.3%) after forest walking; compared with forest walking, DBP was unchanged after city walking. | NA | NA | Compared with city walking, CAVI was significantly lower by 0.42+/−0.72; and FEV1 and FEV6 were increased by 0.19+/−0.26 and 0.22+/−0.36, respectively compared with forest walking, CAVI, FEV1, and FEV6 were unchanged after city walking. |
| Li et al., 2016 [ | No significant difference in systolic blood pressure between forest and urban walking | No significant difference in diastolic blood pressure between forest and urban walking | NA | Forest walking significantly reduced the subjects’ pulse rate by 6.9%. | After forest walking, the serum level of adiponectin was significantly greater than that of urban walking. Forest and urban walks reduced the level of urinary adrenaline, noradrenaline, and dopamine but had no effect on total cholesterol, LDL, HDL, RLP, EIA, blood glucose, serum insulin, and DHEA-S, hs-CRP. |
| Mao et al., 2012 [ | After a 7-day forest walking trip, SBP decreased significantly by 8 mmHg (5.4%) compared with that of the city group; after a 7-day city walking trip, SBP showed little change compared with that of the forest walking group. | After a 7-day forest walking trip, DBP decreased significantly by 6 mmHg (7%) compared with that of the city group; after a 7-day city walking trip, DBP showed little change compared with that of the forest walking group. | Heart rate did not change in either of the two groups before and after the experimental intervention. | Pulse rate did not change in either of the two groups before and after the experimental intervention. | At the end of the 7-day trip, ET-1, Hcy, AGT, AT1, and AT2 levels were significantly lower in the forest group. There were no significant alterations in these factors in the city group. The serum IL-6 level in the forest group was lower in comparison with its baseline level. |
| Song et al., 2015 [ | NA | NA | Compared with urban walking, mHF was 10% higher in forest walking; compared with urban walking, mHR was 1.9% lower in forest walking. | NA | NA |
| Yu et al., 2017 [ | Pretest: 129.9 ± 17.5 mmHg; post-test: 124.8 ± 16.5 mmHg; significantly lower by 3.9% after forest walking | Pretest: 85.3 ± 9.1 mmHg; post-test: 84.0 ± 8.1 mmHg; significantly lower by 1.5% after forest walking | No significant change in HF and LF/HF | Pretest: 73.9 ± 9.4 bpm; post-test: 71.4 ± 8.4 bpm; significantly lower by 3% after forest walking | NA |
| Zhou et al., 2017 [ | After forest walking, SBP decreased by 24.6%; after walking around a highway, SBP decreased by 17%. | After forest walking, DBP decreased by 29.5%; after walking around a highway, DBP decreased by 2%. | After forest walking, HR decreased by 28%; after walking around a highway, HR decreased by 20%. | NA | After forest walking, triacylglycerol, total cholesterol, and cardiac functions improved significantly compared with walking around a highway. |
| Types of forest interventions: sitting and viewing of landscapes in the forest | |||||
| Song et al., 2017a [ | NA | NA | Compared with the urban area, HRV was significantly higher by 30% in forest viewing; no significant difference between the two environments in LF/HF; compared with the urban area, HR was significantly lower by 3.5% in forest viewing | NA | NA |
| Types of forest interventions: forest walking and viewing of landscapes in the forest | |||||
| Lanki et al., 2017 [ | Walking in an urban forest was associated with a 1.9% increase in SBP; sitting and viewing the landscape in an urban forest was associated with no change in SBP; viewing and walking in an urban forest was associated with no change in SBP compared with viewing and walking in an urban park and in the city center | Walking in an urban forest was associated with a 2.5% increase in DBP; sitting and viewing the landscape led to lower DBP compared with sitting and viewing the landscape in an urban park and in the city center; viewing and walking in urban forest was associated with no change in DBP compared with viewing and walking in an urban park and in the city center | Walking in a forest was associated with a 5.4% lower heart rate and a higher HF by over 100%; viewing of landscapes in a forest area was associated with a 6.5% lower heart rate and a 25% higher HF after the intervention. | NA | NA |
| Horiuchi et al., 2015 [ | After forest walking, SBP decreased significantly by 11% and 5% in the responder group (> 5% MAP decrease) and non-responder group (< 5% MAP decrease), respectively | After forest walking, DBP decreased significantly by 5% in the responder group (> 5% MAP decrease) but was unchanged in the non-responder group (< 5% MAP decrease) | NA | NA | No improvement in salivary amylase (sAmy) was observed before and after forest walking in both the responder group and the non-responder group |
| Types of forest interventions: forest therapy program | |||||
| Ochiai et al.,2015b [ | NA | NA | NA | Pretest: 73.1 ± 2.5 bpm; post-test: 69.1 ± 2.7 bpm; significantly lower after forest therapy by 4.67 bpm (5.4%) | Salivary cortisol concentration: pretest: 0.168 ± 0.020 μg/dL; post-test: 0.124 ± 0.009 μg/dL; significantly lower after forest therapy by 2.63 μg/dL |
| Ochiai et al., 2015a [ | Pretest: 140.1 mmHg, post-test: 123.9 mmHg; significantly lower by 16.1 mmHg (11.5%) | Pretest: 84.4 mmHg; post-test: 76.6 mmHg ; significantly lower by 7.8 mmHg (9.2%) | NA | NA | Salivary cortisol concentration, pretest: 7.4 μg/dL; post-test:4.9 μg/dL significantly lower after forest therapy by 2.5 μg/dL; urinary creatinine correction, pretest: 13.1 μg/g creatinine; post-test: 11.0 μg/g creatinine; significantly lower after forest therapy by 2.1 μg/g creatinine |
| Song et al., 2017b [ | 5 days after: decreased significantly by 3.5% (pre: 114.8 ± 2.7 mmHg; post: 110.7 ± 2.6 mmHg); higher than 120 mmHg group ( | 5 days after: Decreased significantly by 2.8% (pre: 75.0 ± 2.3 mmHg; post: 72.9 ± 2.1 mmHg); higher than 120 mmHg group ( | NA | Pulse rate: no significant change | NA |
| Sung et al., 2012 [ | 8 weeks after: I, −12.0 ± 9.2 mmHg; C, 11.5 ± 19.9 mmHg; decreased by 9 % from the initial measurement in the forest group compared with the control group | 8 weeks after: I, no change; C, 1.3 ± 13.3; DBP did not show a significant change from the baseline, and self-measured SBP and DBP at week 4 and week 8 did not differ from the baseline measurements. | NA | NA | Salivary cortisol level: significantly reduced in the forest group by 0.03 μg/dL; in the control group, the salivary cortisol level increased slightly at the follow-up. |
FMD flow mediated dilation; NMD nitro-glycerine mediated dilation; IMT carotid intima media thickness; BaPWV brachial-ankle pulse wave velocity; TG triglycerides; LDL low density lipoprotein; HDL high density lipoprotein; RLP remnant-like particles; DHEA-S the serum level of dehydroepiandrosterone sulfate; hs-CRP the serum level of high-sensitivity C-reactive protein; GH general health, PD physical dimension; MD mental dimension; SD social dimension; HTN hypertension-related dimension; CAVI cardio-ankle vascular index; FEV1 forced expiratory volume in 1 s; FEV6 forced expiratory volume in 6 s; ET-1 endothelin-1, Hcy homocysteine, RAS renin-angiotensin system; AGT angiotensinogen; Ang II angiotensin II; AT1 angiotensin II type 1 receptor, AT2 angiotensin II type 2 receptor; IL-6 the production of interleukin-6 and TNF-α tumor necrosis factor-alpha; HR heart rate; LF/HF low frequency/high frequency; mHF mean high frequency
Summary of outcomes measures on psychological response of the included studies
| Reference/participants | Change in mood states | Change in quality of life (QoL)/anxiety level measures |
|---|---|---|
| Types of forest interventions: forest walking | ||
| Feng et al., 2017 [ | NA | NA |
| Lee and Lee, 2014 [ | NA | NA |
| Li et al., 2016 [ | POMS scores indicated a significant increase in positive feelings (vigor) and a significant decrease in negative feelings (tension, anxiety, depression, confusion, fatigue) after forest walking. POMS scores indicated a significant decrease in positive feelings (vigor) and a significant increase in negative feelings of fatigue after urban walking. | NA |
| Mao et al., 2012 [ | POMS scores indicated a significant increase in positive feelings (vigor) and significant decrease in negative feelings (anxiety, depression, confusion, fatigue, anger) after forest walking compared with the baseline. POMS scores indicated a significant decrease in positive feelings (vigor) and no significant increase in negative subscales after urban walking. | NA |
| Song et al., 2015 [ | POMS scores were significantly higher for positive feelings (vigor) and significantly lower for negative feelings (anxiety, depression, confusion, fatigue, anger) after forest walking than after urban walking. SDM score: Participants felt more “comfortable,” “relaxed,” and “natural” when they walked in a forest area than in an urban area. | NA |
| Yu et al., 2017 [ | POMS score: There was a significant increase in positive feelings (vigor) and a significant decrease in negative feelings (tension anxiety, fatigue, anger, depression, confusion) after forest therapy. | STAI was taken before and after the intervention STAI: State anxiety subscale A decrease in score of 2% represented a significant improvement in anxiety levels |
| Zhou et al., 2017 [ | NA | NA |
| Types of forest interventions: sitting and viewing of landscapes in a forest | ||
| Song el at., 2017a [ | SDM: Viewing in a forest area felt more comfortable, relaxed, and natural than in an urban area | NA |
| Types of forest interventions: forest walking and viewing of landscape in a forest | ||
| Lanki et al., 2017 [ | NA | NA |
| Horiuchi et al., 2015 [ | POMS score: There was a significant increase in positive feelings (Vigour) and a significant decrease in negative feelings (tension anxiety, fatigue, anger, depression, confusion) after forest therapy. There were no significant differences between the groups in the pre-forest-walking values of the subscales of the POMS, with the exception of A-H. Forest walking significantly improved the subscales of the POMS in both groups with no statistical differences between the two groups. | NA |
| Types of forest interventions: forest therapy program | ||
| Ochiai et al., 2015b [ | SD score: felt more comfortable, relaxed, and natural after forest therapy. POMS score: a significant increase in positive feelings (vigor) and a significant decrease in negative feelings (tension, anxiety, and fatigue) after forest therapy. | |
| Ochiai et al., 2015a [ | SD score: felt more comfortable, relaxed, and natural after forest therapy. POMS score: a significant increase in positive feelings (vigor) and a significant decrease in negative feelings (tension anxiety, confusion, anger, fatigue, and total mood disturbance) after forest therapy. | NA |
| Song et al., 2017b [ | NA | NA |
| Sung et al., 2012 [ | NA | Quality of life (QoL) scores were obtained at initial visits and at 8-week final visits. MOS SF-36: I, total score increased by 42 compared with the baseline; score increased in PD, MD, HTN by 9, 16, 18, respectively but remained unchanged in SD and GH; C, no change |
LDL low-density lipoprotein; HDL high-density lipoprotein; RLP remnant-like particles; DHEA-S the serum level of dehydroepiandrosterone sulfate; hs-CRP the serum level of high-sensitivity C-reactive protein; SD the modified semantic differential; POMS the Profile of Mood state; HF high-frequency; LF low-frequency, GH general health; PD physical dimensions; MD mental dimension; SD social dimension; HTN hypertension-related dimension